CHLA-53
Resource Report
Resource Website
|
RRID:CVCL_AQ16
|
Homo sapiens (Human)
|
Neuroblastoma
|
|
PMID:24792489
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54812501 |
|
|
CVCL_AQ16 |
2026-07-25 04:23:47 |
0 |
CHLA-20
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_6602
|
Homo sapiens (Human)
|
Neuroblastoma
|
|
PMID:9850071 PMID:23202128 PMID:24792489
|
Cancer cell line
|
Female |
CHLA20 |
|
|
Cell_Model_Passport:SIDM01539, Cosmic:1890108, Wikidata:Q54812179 |
|
|
CVCL_6602 |
2026-07-25 04:23:45 |
4 |
CHLA-42
Resource Report
Resource Website
|
RRID:CVCL_6603
|
Homo sapiens (Human)
|
Neuroblastoma
|
|
PMID:9850071 PMID:11212268 PMID:23202128 PMID:24792489
|
Cancer cell line
|
Sex unspecified |
CHLA_42 |
|
|
Cosmic:930039, Cosmic:1890123, Wikidata:Q54812498 |
|
|
CVCL_6603 |
2026-07-25 04:23:47 |
0 |
IGR-N-91
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_8883
|
Homo sapiens (Human)
|
Neuroblastoma
|
|
PMID:8101511 PMID:10686938 PMID:11464856 PMID:14676279
|
Cancer cell line
|
Male |
IGR-N91, IGRN91, Institut Gustave Roussy-Neuroblastoma-91 |
|
|
IARC_TP53:24361, Wikidata:Q54897379 |
|
|
CVCL_8883 |
2026-07-25 04:46:41 |
1 |
IMR-5rCDDP1000
Resource Report
Resource Website
|
RRID:CVCL_RR56
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:24466371 PMID:31581737
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897652 |
cvcl_1306 |
|
CVCL_RR56 |
2026-07-25 04:46:51 |
0 |
IMR-32rMEL500
Resource Report
Resource Website
|
RRID:CVCL_RR71
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:24466371 PMID:31581737
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897637 |
cvcl_0346 |
|
CVCL_RR71 |
2026-07-25 04:46:47 |
0 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
JCRB Cat# IFO50283, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
JCRB |
IFO50283 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:46 |
343 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
|
|
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:46 |
343 |
IMR-32/CMV-Luc
Resource Report
Resource Website
Discontinued
|
RRID:CVCL_A9J0
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1482)., Population: Caucasian.
|
|
Cancer cell line
|
Male |
IMR-32 CMV-Luc |
|
|
JCRB:JCRB1842, JCRB:NIHS1296, Wikidata:Q102114223 |
cvcl_0346 |
|
CVCL_A9J0 |
2026-07-25 04:46:46 |
0 |
IMR-5rGEMCI20
Resource Report
Resource Website
|
RRID:CVCL_RR60
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:24466371
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897658 |
cvcl_1306 |
|
CVCL_RR60 |
2026-07-25 04:46:51 |
0 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
CCTCC Cat# GDC0107, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
CCTCC |
GDC0107 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:50 |
343 |
IMR-5rMEL1000
Resource Report
Resource Website
|
RRID:CVCL_RS62
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897660 |
cvcl_1306 |
|
CVCL_RS62 |
2026-07-25 04:46:47 |
0 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
DSMZ Cat# ACC-165, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
DSMZ |
ACC-165 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:50 |
343 |
IMR-32rGEMCI20
Resource Report
Resource Website
|
RRID:CVCL_RS53
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897634 |
cvcl_0346 |
|
CVCL_RS53 |
2026-07-25 04:46:47 |
0 |
IMR-32rTOPO8
Resource Report
Resource Website
|
RRID:CVCL_RS57
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:31581737
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897643 |
cvcl_0346 |
|
CVCL_RS57 |
2026-07-25 04:46:51 |
0 |
IMR-32
Resource Report
Resource Website
100+ mentions
Discontinued Possibly Discontinued
|
Coriell Cat# GM03320, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
Coriell |
GM03320 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:46 |
343 |
IMR-32rCDDP1000
Resource Report
Resource Website
|
RRID:CVCL_RR67
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:24466371
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897627 |
cvcl_0346 |
|
CVCL_RR67 |
2026-07-25 04:46:50 |
0 |
IMR-5rPCL20
Resource Report
Resource Website
|
RRID:CVCL_RR63
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
PMID:24466371
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897663 |
cvcl_1306 |
|
CVCL_RR63 |
2026-07-25 04:46:47 |
0 |
IMR-32rCARBO5000
Resource Report
Resource Website
|
RRID:CVCL_RS61
|
Homo sapiens (Human)
|
Neuroblastoma
|
Population: Caucasian., Part of: Resistant Cancer Cell Line (RCCL) collection.
|
|
Cancer cell line
|
Male |
|
|
|
Wikidata:Q54897626 |
cvcl_0346 |
|
CVCL_RS61 |
2026-07-25 04:46:46 |
0 |
IMR-32
Resource Report
Resource Website
100+ mentions
Possibly Discontinued Discontinued
|
Coriell Cat# AG03320, RRID:CVCL_0346
|
Homo sapiens (Human)
|
Neuroblastoma
|
Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449
|
Cancer cell line
|
Male |
IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 |
Coriell |
AG03320 |
BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
|
|
CVCL_0346 |
2026-07-25 04:46:46 |
343 |